Kaux Jean-François, Croisier Jean-Louis, Léonard Philippe, Le Goff Caroline, Crielaard Jean-Michel
*Physical Medicine and Sport Traumatology Service, Motility Sciences Department, University Hospital of Liège, University of Liège, Liège, Belgium; †Infectious Diseases Service, University Hospital of Liège, Liège, Belgium; and ‡Clinical Chemistry Service, University Hospital of Liège, Liège, Belgium.
Clin J Sport Med. 2014 Mar;24(2):150-2. doi: 10.1097/JSM.0b013e31829aa410.
Platelet-rich plasma (PRP) contains a large number of growth factors, which may enhance tendon healing processes. Local injection of PRP represents a relatively new treatment for tendinopathies. To date, no side effects have been reported after injection of PRP to treat tendinopathy. We report a case of exuberant inflammatory reaction after 1 injection of PRP to treat jumper's knee in a 35-year-old male type 1 diabetic patient. Injections of PRP should be proposed only after careful consideration in cases of patients with morbidity risks linked to insulin-dependent diabetes.
富含血小板血浆（PRP）含有大量生长因子，可能会促进肌腱愈合过程。局部注射PRP是治疗肌腱病的一种相对较新的疗法。迄今为止，尚未有注射PRP治疗肌腱病后出现副作用的报道。我们报告一例35岁1型糖尿病男性患者注射1次PRP治疗跳跃膝后发生的过度炎症反应病例。对于有胰岛素依赖型糖尿病相关发病风险的患者，仅在仔细考虑后才可建议注射PRP。
